← All companies

SRPT

Sarepta Therapeutics, Inc.

SRPT Nasdaq Pharmaceutical Preparations EDGAR ↗

$15.88

+1.02 +6.86%

Key statistics

from XBRL data in SEC filings

Market cap

$1.68B

Revenue (TTM)

$1.66B

Net income (TTM)

$65.1M

EPS (TTM)

$0.34

P/E ratio

46.7

Dividend yield

—

Free cash flow

-$307M

Cash

$464M

Total assets

$3.18B

Gross margin

61.9%

52-week range

$14.68 – $25.32

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Regulation FD disclosure Jul 27, 2026 8-K Director or officer change; Shareholder vote results Jun 4, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Director or officer change Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation Dec 19, 2025 8-K Unregistered sale of equity; Other events Dec 11, 2025 8-K Director or officer change Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Aug 29, 2025 8-K Unregistered sale of equity Aug 21, 2025 8-K Director or officer change Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Other events Jul 21, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change Jul 16, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Entered a material agreement; Took on a direct financial obligation Feb 14, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Entered a material agreement Nov 26, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Director or officer change; Amended charter or bylaws Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Director or officer change; Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 1, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Regulation FD disclosure Jun 22, 2023 8-K Regulation FD disclosure Jun 22, 2023 8-K Director or officer change; Shareholder vote results Jun 9, 2023 10-Q Quarter ended 2023-03-31 May 2, 2023 8-K Entered a material agreement; Unregistered sale of equity Mar 3, 2023